Clinical Pharmacology and Therapeutics

SGLT2 Inhibitors and Asthma Exacerbation Risk Among Patients With Type 2 Diabetes and Asthma: A Target Trial Emulation

By Kevin Yi-Chen Liao, Daniel Hsiang-Te Tsai, Michael Chun-Yuan Cheng, Edward Chia-Cheng Lai

Study in peopleInterventions

The paper

Kevin Yi-Chen Liao, Daniel Hsiang-Te Tsai, Michael Chun-Yuan Cheng, Edward Chia-Cheng Lai

National Cheng Kung University

Clinical Pharmacology and Therapeutics, 6 Oct 2026

doi.org/10.1002/cpt.70514 PubMed 42839355

Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs